Texray AB | Gothenburg, Sweden | June 10, 2022 |

Swedish innovation reduces radiation doses for interventional operators

Texray, the Swedish innovation company developing Occupational Radiation Equipment, today announces the acceptance for a scientific poster publication during EuroPCR, the annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology, that took place May 17-20th 2022 in Paris, France.

“EuroPCR has a high impact on the cardiovascular community, and Texray products receiving recognition at this prestigious event demonstrate the need  to enhance radiation protection for medical practitioners,” said Jeffrey B. Jump, Chairman of the Board at Texray. “We have seen an elevating need for ergonomic and innovative solutions in the past few years. Medical professionals are becoming more aware and concerned about occupational health risks that may be related to radiation exposure, which we have decided to act on.

An overview of the published poster at EuroPCR 2022 is included below.

Swedish innovation reduces radiation doses for interventional operators.


  1. Klinikum Dortmund gGmbH, Department of Medical Physics and Radiation Protection, Beurhausstr. 40, 44137 Dortmund.
  2. Klinikum Dortmund gGmbH, Department of Radiology and Neuroradiology, Beurhausstr. 40, 44137 Dortmund, Germany
  3. Texray AB, Stena Center 412 92, Gothenburg, Sweden

Being exposed to ionizing radiation may cause diseases such as: cancer and cognitive impairments, and over 50% of OR staff do not feel adequately protected from radiation. However, the risk for developing radiation-induced diseases is still an ongoing debate among experts.Thus, why should one not try to reduce as much radiation as possible? Amount of radiation doses are depending on factors such as patient obesity, procedural complexity, fluoroscopy time and Operators individual sensitivity. A recent clinical evaluation (Bärenfänger F., Rohde S.) and Phantom study (Apell P., Larsson M.) shows that a novel radiation protection system with a unique design may reduce radiation doses towards the head and neck region by up to additional 97%, when compared to standard thyroid collars.

The full abstract is published on EuroPCR online, link provided below.